Calculus VCT - Half-year Financial Report
Calculus VCT plc
Half Yearly Report for the six months ended
INVESTMENT OBJECTIVE
The Company's principal objectives for investors are to:
● invest in a portfolio of Venture Capital Investments that will provide investment returns that are sufficient to allow the Company to maximise dividends and capital growth over the medium to long term;
● generate sufficient returns from a portfolio of Venture Capital Investments that will provide attractive long-term returns within a tax efficient vehicle;
● review and pay the appropriate level of dividends annually taking account of investment returns achieved and future prospects; and
● maintain VCT status to enable qualifying investors to retain their income tax relief of up to 30 per cent. on the initial investment and receive tax-free dividends and capital growth.
FINANCIAL OVERVIEW
|
Financial Highlights |
6 months to |
|
12 months to |
|
6 months to |
|
|
pence |
|
pence |
|
pence |
|
Opening net asset value |
59.04 |
|
61.58 |
|
61.58 |
|
Capital loss |
(0.60) |
|
1.50 |
|
(1.74) |
|
Revenue return |
(0.05) |
|
0.30 |
|
0.22 |
|
Total return1 |
(0.65) |
|
1.80 |
|
(1.52) |
|
Dividends paid |
(1.81) |
|
(3.91) |
|
(2.77) |
|
Impact of share capital movements |
(0.15) |
|
(0.43) |
|
(0.09) |
|
Closing net asset value |
56.43 |
|
59.04 |
|
57.20 |
|
Total Shareholder value |
Ordinary shares (pence per share) |
|
Total dividends paid to |
29.60 |
|
Net asset value on |
56.43 |
|
Total shareholder value to |
86.03 |
2 total dividends paid include cumulative dividends paid since 2017
|
|
56.43p |
|
1.08X |
|
|
|
|
38 |
Historical Total Return
|
Financial period-end |
NAV at period-end |
Cumulative dividends received (p)* |
Total return (p)** |
|
|
56.43 |
- |
56.43 |
|
|
57.2 |
2.95 |
59.38 |
|
|
61.55 |
5.72 |
62.15 |
|
|
64.61 |
8.67 |
65.1 |
|
|
64.01 |
11.73 |
68.16 |
|
|
64.27 |
14.75 |
71.18 |
* Cumulative dividends received includes all dividends received since the relevant Financial period-end to date
** Total NAV return is equal to the sum of NAV at
CHAIRMAN'S UPDATE
I am pleased to present your Company's results for the 6 months to
Performance summary
The Company has maintained a positive total return over a 2-year and 5-year period across the qualifying portfolio. The NAV at the period end was
The strongest positive movement within the qualifying portfolio was generated by Quai Administration Services, which sits within the technology segment. Quai provides platform technology and back-office administration services to the high-volume personal savings sector. The business has grown substantially in recent years and now oversees more than
Insurtech business Optalitix continued the strong momentum that made it the top-performing company in the 12 months to
Arecor, the drug discovery firm and one of only two AIM-listed companies within the portfolio, contributed a similar level of growth to the NAV per share. Improved investor sentiment led to a share price increase in the six months to
Given the broader economic and political environment and the recent period of instability, some valuation reductions across parts of the portfolio were unavoidable. These adjustments reflect the balanced and prudent valuation approach adopted by Calculus Capital as the Investment Manager. Home Team Content, a UK-based production company focused on elevating underrepresented voices, particularly filmmakers of colour and women , experienced a reduction in carrying value due to certain development delays. Nevertheless, the company remains committed to progressing its slate through strategic partnerships, distribution agreements, and new revenue opportunities.
IPV, a provider of proprietary software that enables efficient access, storage, modification, tagging, and transfer of video content, also saw a decline in its carrying value in the six months to
Overall, the Company portfolio and sector balance continues to provide long term growth for shareholders. This has been recognised with one of the most successful fundraising periods for the Company across the 25/25 & 25/26 tax year share offer.
New and Follow on Investments
In
To further enhance the Company's life sciences sector, a follow-on investment was made in Laverock Therapeutics, with the company raising
During the 6 months to
Company Exits
The six months to
Following the half year-end, in
In the year to
New investment
|
Date of Investment |
Name of Investment |
Location |
Sector |
Amount of Investment |
|
|
Smartr365 Finance Limited
|
United Kingdom |
Technology |
|
|
|
BookedIt Limited |
United Kingdom |
Technology |
|
|
|
Ensilicated Technologies Limited |
United Kingdom |
Healthcare |
|
Follow-on Investments
|
Date of Investment |
Name of Investment |
Location |
Sector |
Amount of Investment |
|
|
Rain Dog Films Limited
|
United Kingdom |
Entertainment |
450,000.00
|
|
|
Notify Technology Limited
|
United Kingdom |
Technology |
|
|
|
Laverock Therapeutics Limited
|
United Kingdom |
Healthcare |
|
|
|
IPV Limited |
United Kingdom |
Technology/Healthcare |
|
|
|
Laverock Therapeutics Limited |
United Kingdom |
Healthcare |
|
|
|
Riff Raff Entertainment Limited |
United Kingdom |
Entertainment |
|
|
|
Invizius Limited |
United Kingdom |
Healthcare |
|
|
|
Quai Administration Services Limited |
United Kingdom |
Technology |
|
|
|
Engaging Works Holding Limited
|
United Kingdom |
Technology |
|
We believe the portfolio is well positioned to continue to provide long term growth to shareholders and that our Investment Manager is similarly positioned to exploit these opportunities.
Buybacks
During the period, the Company bought back and cancelled 1,272,463 Ordinary shares. The Company continues to review opportunities to carry out share buybacks at a discount of no greater than 5% to NAV.
Dividends
As mentioned above, a dividend was paid on 2nd
Board composition
The board consist of three Directors, two of which are independent from the Manager. Janine Nicholls stepped down from the Board of Directors with effect from
Ordinary share issue
The offer for subscription for Ordinary Shares that opened on
Developments since the period end
In
These two new investments represent
As mentioned above, in
In
The new investments, profitable exits and buy backs in the subsequent months since the
On the 26th November we heard what has been a long anticipated and purposely delayed Autumn budget. For months, warnings of potential tax hikes in various forms have dominated the headlines, and at times it appeared almost inevitable that Labour would break their manifesto pledge to leave income tax rates untouched. However, improved economic forecasts allowed the Chancellor to step back from this move.
The Chancellor has consistently expressed support for EIS and VCT legislation, recognising the role both schemes play in channelling capital into early-stage companies and promoting broader economic growth. This support was further reinforced by the Budget announcement to raise the annual and lifetime limits on the amount of EIS an VCT investment a single company can receive. However, a more counterintuitive change came in the form of the reduction of the income tax relief available through VCTs, reduced from 30% to 20%. This change comes despite the Chancellor's longstanding support for VCTs and their role in fostering growth and backing the UK's early-stage business ecosystem. The rationale given for this is to further balance the tax reliefs available across VCTs and EIS, with the change tax relief to be effective from
From
Jan Ward
Chairman
INTERIM MANAGEMENT REPORT
Venture Capital Investments
Portfolio developments
Calculus Capital Limited manages the Company's portfolio of venture capital investments. In general, Calculus Capital prefers investments to be of a sufficient size to enable them to play an influential role in helping the investee companies develop. Investments by the Company are primarily in equity but may also be by way of loan stock and/or preference shares which provide income to assist in paying dividends and provide a measure of risk mitigation.
As at
Optalitix Limited
Optalitix has maintained strong momentum since the year-end, with Contracted Annual Recurring Revenue rising over 20%. Building on high-profile implementations with Pool Re and Tokio Marine, the Company is seeing particular traction in the reinsurance market, where demand for scalable cloud-based underwriting solutions continues to grow. These results highlight the accelerating adoption of Optalitix's low-code SaaS platforms and reinforce its position as a key technology partner to leading specialty insurers and reinsurers in the insurance market and lenders in the banking market.
Quai Administration Services Limited ("Quai")
Quai provides platform technology combined with back-office administration services for the high-volume personal savings industry. Quai has grown considerably over recent years, the Company now has over
Riff Raff Entertainment Limited ("Riff Raff")
Riff Raff, co-founded by Jude Law and Ben Jackson, is a UK-based production company known for bold, character-driven storytelling. Its latest project, Black Rabbit, is an eight-part Netflix drama starring Jude Law and Jason Bateman, who also directs some of the episodes. Created by Zach Baylin and Kate Susman, the series explores the tense relationship between two brothers in New York's restaurant scene. Black Rabbit marks Riff Raff's first fully originated episodic TV production-a major creative milestone for the Company. With a growing team in the UK and expanding presence in the US, the Company is actively building bridges between the two markets to support its long-term growth and has a number of series in development with streamers, studios and broadcasters.
Brouhaha Entertainment Limited ("Brouhaha")
Brouhaha, based in London and Sydney, is a film and television production company founded by experienced industry professionals. After the phenomenal success of the TV Series Boy Swallows Universe on Netflix in 2024, topping charts in multiple countries, Brouhaha is working on several other TV series and films in paid development with leading streamers and broadcasters. The film Dangerous Animals, shot in Australia and released in
Oxford BioTherapeutics Limited ("OBT")
OBT is a clinical stage oncology company that is developing a pipeline of novel immunotherapy drug candidates in partnership with major pharma companies. In
Blu Wireless Technologies ("Blu Wireless")
Blu Wireless achieved a major milestone with its first defence program successfully delivered and deployed in the field for the US Army, earning strong endorsement from key military stakeholders. The Company continues to strengthen its US defence positioning. In rail, global project delays persist, though Blu Wireless is leveraging its strategic partnership with Westermo to progress commercial opportunities as well as engaging directly with key potential customers and partners.
The BookedIt Group Limited ("Booked It")
Booked It is a B2B SaaS and payments company that provides booking, ticketing, payments, marketing, CRM and loyalty software in one hosted platform. The Company serves a number of different industries including family entertainment (soft play centres/water parks), competitive socialising (bowling alleys/escape rooms) and visitor attractions (museums/cinemas). The Company has performed well since the first Calculus investment in
Home Team Content Limited ("Home Team")
Home Team Content, founded in 2021 by Dominic Buchanan and Bennett McGhee, is a UK-based production company dedicated to amplifying underrepresented voices, especially filmmakers of colour and women. Its debut feature, ISH, premiered at the Venice and BFI London Film Festivals in 2025. While development delays have impacted valuation, the Company remains focused on advancing its slate in the months ahead through strategic partnerships, distribution deals, and new revenue opportunities.
Developments since the period end
As mentioned above, the Company invested an additional
Calculus Capital Limited
Investment Manager
INVESTMENT PORTFOLIO AS AT
- TOTAL FUND
% of Net Assets
|
|
|
|
Unquoted - loan stock |
6% |
|
Quoted and unquoted - ordinary and preference shares |
70% |
|
Unquoted - liquidity funds |
20% |
|
Net current assets |
7% |
|
|
100% |
|
|
|
Asset class - % of Portfolio
|
Company |
Book Cost |
Market Valuation as at |
Multiple against book cost as at |
Multiple against book cost as |
Market Value Movement since |
% of portfolio |
|
Qualifying Investments |
|
|
|
|
|
|
|
Arctic Shores Limited |
610 |
610 |
1.00x |
1.00x |
0.0% |
1.4% |
|
Arecor Therapeutics plc |
833 |
375 |
0.45x |
0.22x |
102.7% |
0.8% |
|
Blu Wireless Technology Limited |
833 |
1,574 |
1.89x |
1.76x |
7.4% |
3.5% |
|
Bookedit Limited |
1,570 |
1,570 |
1.00x |
1.00x |
0.0% |
3.5% |
|
Brouhaha Entertainment |
1,331 |
2,503 |
1.88x |
1.88x |
0.0% |
5.5% |
|
C4X Discovery Holdings |
598 |
521 |
0.87x |
1.05x |
-16.6% |
1.2% |
|
Censo Biotechnologies Limited |
1,051 |
1,014 |
0.96x |
0.95x |
1.6% |
2.2% |
|
Engaging Works Investments Limited |
1,204 |
1,287 |
1.07x |
1.00x |
6.9% |
2.9% |
|
Ensilicated Technologies Limited |
753 |
753 |
1.00x |
New |
New |
1.7% |
|
Evoterra Limited |
1,215 |
200 |
0.16x |
0.16x |
0.0% |
0.4% |
|
Fiscaltec Group Limited |
768 |
1,700 |
2.21x |
2.00x |
10.5% |
3.8% |
|
Home Team Content Limited |
786 |
1,493 |
1.90x |
2.78x |
-31.8% |
3.3% |
|
Huma Therapeutics Limited |
262 |
264 |
1.01x |
1.01x |
0.0% |
0.6% |
|
Invizius Limited |
625 |
309 |
0.49x |
0.77x |
-35.5% |
0.7% |
|
IPV Limited |
1,330 |
1,526 |
1.15x |
1.43x |
-19.5% |
3.4% |
|
Laverock Therapeutic Limited |
1,176 |
1,176 |
1.00x |
1.00x |
0.0% |
2.6% |
|
Maven Screen Media Limited |
798 |
853 |
1.07x |
1.27x |
-16.1% |
1.9% |
|
MIP Diagnostics Limited |
982 |
960 |
0.98x |
1.10x |
-10.9% |
2.1% |
|
Notify Technology Limited |
860 |
963 |
1.12x |
1.12x |
0.0% |
2.1% |
|
Open Energy Market Limited |
200 |
704 |
3.52x |
3.52x |
0.0% |
1.6% |
|
Optalitix Limited |
1,347 |
2,557 |
1.90x |
1.75x |
8.3% |
5.7% |
|
Oxford BioTherapeutics Limited |
350 |
1,773 |
5.07x |
5.07x |
0.0% |
3.9% |
|
Quai Administration Services Limited |
1,531 |
2,624 |
1.71x |
1.01x |
69.7% |
5.8% |
|
Raindog Films Limited |
846 |
604 |
0.71x |
0.88x |
-19.1% |
1.3% |
|
Riff Raff Entertainment Limited |
1,374 |
2,645 |
1.93x |
1.93x |
0.0% |
5.9% |
|
Scancell Holdings plc |
378 |
249 |
0.66x |
0.54x |
21.5% |
0.6% |
|
Smart365 Finance Limited |
743 |
743 |
1.00x |
1.00x |
0.0% |
1.6% |
|
Tagomics Limited |
909 |
1,000 |
1.10x |
1.10x |
0.0% |
2.2% |
|
Thanksbox Limited |
1,073 |
1,363 |
1.27x |
1.10x |
15.8% |
3.0% |
|
Wazoku Limited |
720 |
588 |
0.82x |
0.94x |
-13.0% |
1.3% |
|
Wonderhood Limited |
441 |
723 |
1.64x |
1.64x |
0.0% |
1.6% |
|
Other* |
1,896 |
269 |
0.14x |
0.44x |
-17.3% |
0.6% |
|
|
|
|
|
|
|
|
|
Total Qualifying Investments |
29,393 |
35,493 |
|
|
|
78.7% |
|
|
|
|
|
|
|
|
|
Other non-Qualifying Investments |
|
|
|
|
|
|
|
Aberdeen Sterling Liquidity Fund |
3,107 |
3,107 |
1.00x |
1.00x |
14.8% |
6.9% |
|
Fidelity Sterling Liquidity Fund |
3,082 |
3,406 |
1.11x |
1.06x |
-10.2% |
7.5% |
|
Goldman Sachs Sterling Liquidity Fund |
3,105 |
3,105 |
1.00x |
1.00x |
14.8% |
6.9% |
|
Total other non-qualifying investments |
9,294 |
9,618 |
|
|
|
21.3% |
|
Total investments |
38,687 |
45,111 |
|
|
|
|
|
Net Current Assets less Creditors due after one year |
|
1,460 |
|
|
|
|
|
Net Non-Current Assets less Creditors due after one year |
|
612 |
|
|
|
|
|
Net Assets |
|
47,183 |
|
|
|
|
|
|
|
|
|
|
|
|
*All individual investee companies with a market value of less than
PRINCIPAL RISKS
The principal risks facing the Company remain the same as those detailed on pages 32 to 35 of the Annual Report and Accounts for the period ended
Brexit is still causing uncertainty however it remains our view that our portfolio companies are not experiencing material difficulties as a result of the political situation.
Regulatory and Compliance risks remain prevalent as the Company is listed on The London Stock Exchange and is required to comply with the listing rules of the Financial Conduct Authority, as well as with the Companies Act, Accounting Standards and various other legislations.
The main risks faced by the Company include, but are not limited to, loss of approval as a venture capital trust and other regulatory breaches, risks of making and realising qualifying investments, liquidity/marketability risk, changes in legislation/taxation, engagement of third-party advisers, market price risk and credit risk.
GOING CONCERN
After making enquiries, and having reviewed the portfolio, balance sheet and projected income and expenditure for the next twelve months, the Directors have a reasonable expectation that the Company has adequate resources to continue in operation for the foreseeable future. The Directors have therefore adopted the going concern basis in preparing these condensed financial statements.
DIRECTORS' RESPONSIBILITY STATEMENT
The Directors confirm that to the best of their knowledge the half-yearly financial report, which has been prepared in accordance with the UK Listing Authority Disclosure and Transparency Rules ("DTR") and in accordance with the Financial Reporting Council's Financial Reporting Standard 104: 'Interim Financial Reporting' gives a true and fair view of the assets, liabilities, financial position and the net return of the Company as at
The Directors confirm that the Chairman's Update, the Investment Management report, the disclosures above and notes 10 and 11, include a fair review of the information required by DTR 4.2.7R, being an indication of important events that have occurred during the first six months of the financial year and their impact on the condensed set of financial statements and a description of the principal risks and uncertainties for the remaining six months of the financial year, and DTR 4.2.8R.
The Directors of Calculus VCT plc are:
Jan Ward
Hemant Mardia
John Glencross
By order of the Board
Jan Ward
Chairman,
CONDENSED INCOME STATEMENT
FOR THE PERIOD FROM
|
|
|
6 Months Ended |
6 Months Ended |
Year Ended |
||||||
|
|
|
|
|
|
||||||
|
|
|
Revenue |
Capital |
Total |
Revenue |
Capital |
Total |
Revenue |
Capital
|
Total |
|
|
|
Return |
Return |
Return |
Return |
Return |
Return |
Return |
Return |
Total |
|
|
Note |
£'000 |
£'000 |
£'000 |
£'000 |
£'000 |
£'000 |
£'000 |
£'000 |
£'000 |
|
|
|
|||||||||
|
Investment holding losses |
8 |
- |
(86) |
(86) |
- |
(75) |
(75) |
- |
2,348 |
2,348 |
|
Realised gains/(losses) on sales |
8 |
- |
(57) |
(57) |
- |
(859) |
(859) |
- |
(731) |
(731) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Income |
|
310 |
- |
310 |
401 |
- |
401 |
712 |
- |
712 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Investment management fee |
|
(116) |
(349) |
(465) |
(89) |
(267) |
(356) |
(181) |
(542) |
(723) |
|
Other operating expenses |
|
(237) |
- |
(237) |
(161) |
- |
(161) |
(314) |
- |
(314) |
|
|
|
|
|
|
|
|
|
|
|
|
|
(Loss)/profit before taxation |
|
(43) |
(492) |
(535) |
151 |
(1,201) |
(1,050) |
217 |
1,075 |
1,292 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Taxation |
3 |
- |
- |
- |
- |
- |
- |
- |
- |
- |
|
|
|
|
|
|
|
|
|
|
|
|
|
(Loss)/profit for the period |
|
(43) |
(492) |
(535) |
151 |
(1,201) |
(1,050) |
217 |
1,075 |
1,292 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic and diluted deficit per new Ordinary share |
2 |
(0.05)p |
(0.60)p |
(0.65)p |
0.22p |
(1.74)p |
(1.52)p |
0.30p |
1.50p |
1.80p |
|
|
|
|
|
|
|
|
|
|
|
|
*These figures are extracts from audited accounts. The notes form an integral part of these Accounts.
The supplementary revenue return and capital return columns are both prepared in accordance with the Association of Investment Companies ("AIC") Statement of Recommended Practice ("SORP"). No operations were acquired or discontinued during the period. All items in the above statements derive from continuing operations. There were no recognised gains or losses other than those passing through the Income Statement. The notes form an integral part of these condensed financial statements.
CONDENSED STATEMENT OF CHANGES IN EQUITY
FOR THE PERIOD FROM
|
|
|
Share |
|
Capital |
Capital |
Capital |
|
|
|
|
Share |
Premium |
Special |
Redemption |
Reserve |
Reserve |
Revenue |
|
|
|
Capital |
Account |
Reserve |
Reserve |
Realised |
Unrealised |
Reserve |
Total |
|
|
£'000 |
£'000 |
£'000 |
£'000 |
£'000 |
£'000 |
£'000 |
£'000 |
|
For the 6 months to |
|
|
|
|
|
|
|
|
|
|
774 |
32,326 |
10,773 |
111 |
(3,595) |
6,826 |
(1,502) |
45,713 |
|
Profit and total comprehensive income for the year |
|
|
|
|
|
|
|
|
|
Realised losses on investments |
- |
- |
- |
- |
- |
(86) |
- |
(86) |
|
Investment holding losses |
- |
- |
- |
- |
(57) |
- |
- |
(57) |
|
Management fee allocated to capital |
- |
- |
- |
- |
(349) |
- |
- |
(349) |
|
Revenue return after tax |
- |
- |
- |
- |
- |
- |
(43) |
(43) |
|
Total profit/(loss) attributable to shareholders for the year |
- |
- |
- |
- |
(406) |
(86) |
(43) |
(535) |
|
Transactions with shareholders |
|
|
|
|
|
|
|
|
|
New share issue |
75 |
4,261 |
- |
- |
- |
- |
- |
4,336 |
|
Expenses of share issue |
- |
(105) |
- |
- |
- |
- |
- |
(105) |
|
Change in accrual of IFA Commission |
- |
(36) |
- |
- |
- |
- |
- |
(36) |
|
Share buybacks for cancellation |
(13) |
- |
(677) |
13 |
- |
- |
- |
(677) |
|
Dividends paid |
- |
- |
(1,513) |
- |
- |
- |
- |
(1,513) |
|
Total transactions with shareholders |
62 |
4,120 |
(2,190) |
13 |
- |
- |
- |
2,005 |
|
|
|
|
|
|
|
|
|
|
|
Transfer of previously unrealised gain to realised |
- |
- |
- |
- |
316 |
(316) |
- |
- |
|
30 September 2025 |
836 |
36,446 |
8,583 |
124 |
(3,685) |
6,424 |
(1,545) |
47,183 |
|
For the 6 months to 30 September 2024 |
|
|
|
|
|
|
|
|
|
1 April 2024 |
634 |
23,057 |
14,848 |
89 |
(1,918) |
4,074 |
(1,719) |
39,065 |
|
Investment holding losses |
- |
- |
- |
- |
- |
(75) |
- |
(75) |
|
Gain on disposal of investments |
- |
- |
- |
- |
(859) |
- |
- |
(859) |
|
New share issue |
96 |
5,752 |
- |
- |
- |
- |
- |
5,848 |
|
Expenses of share issue |
- |
(113) |
- |
- |
- |
- |
- |
(113) |
|
Share buybacks for cancellation |
(8) |
- |
(472) |
8 |
- |
- |
- |
(472) |
|
Management fee allocated to capital |
- |
- |
- |
- |
(267) |
- |
- |
(267) |
|
Increase in accrual of IFA Commission |
- |
(26) |
- |
- |
- |
- |
- |
(26) |
|
Revenue return after tax |
- |
- |
- |
- |
- |
- |
151 |
151 |
|
Dividends paid |
- |
- |
(1,963) |
- |
- |
- |
- |
(1,963) |
|
Transfer of previously unrealised gain to realised |
- |
- |
- |
- |
(347) |
347 |
- |
- |
|
30 September 2024 |
722 |
28,670 |
12,413 |
97 |
(3,391) |
4,346 |
(1,568) |
41,289 |
|
CONDENSED STATEMENT OF CHANGES IN EQUITY (CONTINUED)
|
|
|
|
|
|
|||
|
|
|
Share |
|
Capital |
Capital |
Capital |
|
|
|
|
Share |
Premium |
Special |
Redemption |
Reserve |
Reserve |
Revenue |
|
|
|
Capital |
Account |
Reserve |
Reserve |
Realised |
Unrealised |
Reserve |
Total |
|
|
£'000 |
£'000 |
£'000 |
£'000 |
£'000 |
£'000 |
£'000 |
£'000 |
|
For the 12 months to 31 March 2025* |
|
|
|
|
|
|
|
|
|
1 April 2024 |
634 |
23,057 |
14,848 |
89 |
(1,918) |
4,074 |
(1,719) |
39,065 |
|
Profit and total comprehensive income for the year |
|
|
|
|
|
|
|
|
|
Realised losses on investments |
- |
- |
- |
- |
(731) |
- |
- |
(731) |
|
Investment holding gains |
- |
- |
- |
- |
- |
2,348 |
- |
2,348 |
|
Management fee allocated to capital |
- |
- |
- |
- |
(267) |
- |
- |
(267) |
|
Revenue return after tax |
- |
- |
- |
- |
- |
- |
217 |
217 |
|
Total profit/(loss) attributable to shareholders for the year |
- |
- |
- |
- |
(1,273) |
2,348 |
217 |
1,292 |
|
Transactions with shareholders |
|
|
|
|
|
|
|
|
|
New share issue |
162 |
9,535 |
- |
- |
- |
- |
- |
9,697 |
|
Expenses of share issue |
- |
(229) |
- |
- |
- |
- |
- |
(229) |
|
Change in accrual of IFA Commission |
- |
(37) |
- |
- |
- |
- |
- |
(26) |
|
Share buybacks for cancellation |
(22) |
- |
(1,232) |
22 |
- |
- |
- |
(472) |
|
Dividends paid |
- |
- |
(2,843) |
- |
- |
- |
- |
(1,963) |
|
Total transactions with shareholders |
140 |
9,269 |
(4,075) |
22 |
- |
- |
- |
5,356 |
|
|
|
|
|
|
|
|
|
|
|
Transfer of previously unrealised gain to realised |
- |
- |
- |
- |
(347) |
347 |
- |
- |
|
31 March 2025 |
774 |
32,326 |
10,773 |
111 |
(3,595) |
6,826 |
(1,502) |
45,713 |
* These figures are extracts from audited accounts. The notes form an integral part of these Accounts.
CONDENSED BALANCE SHEET
AS AT 30 SEPTEMBER 2025
(UNAUDITED)
|
|
|
30 September 2025 |
30 September 2024 |
31 March 2025* |
|
|
Note |
£'000 |
£'000 |
£'000 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Non-current assets |
|
|
|
|
|
Investments at fair value through profit or loss |
8 |
45,111 |
36,726 |
43,695 |
|
Sales awaiting settlement |
|
496 |
1,234 |
1,226 |
|
Fixed interest awaiting settlement |
|
250 |
250 |
251 |
|
|
|
45,857 |
38,210 |
45,172 |
|
|
|
|
|
|
|
Current assets |
|
|
|
|
|
Debtors |
|
952 |
314 |
396 |
|
Cash at bank and on deposit |
|
1,086 |
3,185 |
640 |
|
Total current assets |
|
2,038 |
3,499 |
1,036 |
|
|
|
|
|
|
|
Creditors: amounts falling due within one year Creditors |
|
(578) |
(298) |
(379) |
|
|
|
|
|
|
|
Net current assets |
|
1,460 |
3,201 |
657 |
|
|
|
|
|
|
|
Total assets less current liabilities |
|
47,317 |
41,411 |
45,829 |
|
|
|
|
|
|
|
Non- current liabilities |
|
|
|
|
|
IFA trail commission |
|
(134) |
(122) |
(116) |
|
|
|
|
|
|
|
Total net assets |
|
47,183 |
41,289 |
45,713 |
|
|
|
|
|
|
|
Capital and reserves |
|
|
|
|
|
Called-up share capital |
6 |
836 |
722 |
774 |
|
Share premium account |
|
36,446 |
28,670 |
32,326 |
|
Special reserve |
|
8,583 |
12,413 |
10,773 |
|
Capital redemption reserve |
|
124 |
97 |
111 |
|
Capital reserve - realised |
|
(3,685) |
(3,391) |
(3,595) |
|
Capital reserve - unrealised |
|
6,424 |
4,346 |
6,826 |
|
Revenue reserve |
|
(1,545) |
(1,568) |
(1,502) |
|
Equity shareholders' funds |
|
47,183 |
41,289 |
45,713 |
|
|
|
|
|
|
|
Net asset value per new Ordinary share - basic and diluted |
4 |
56.43 |
57.20p |
59.04p |
* These figures are extracts from audited accounts. The notes form an integral part of these condensed financial statements.
CONDENSED STATEMENT OF CASH FLOW
FOR TO THE PERIOD FROM 1 APRIL 2025 TO 30 SEPTEMBER 2025
(UNAUDITED)
|
|
|
6 Months |
6 Months |
12 Months |
|
|
|
Ended |
Ended |
Ended |
|
|
|
30 September |
30 September |
31 March |
|
|
|
2025 |
2024 |
2025* |
|
|
Note |
£'000 |
£'000 |
£'000 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash flow from operating activities |
|
|
|
|
|
Investment income received |
|
256 |
213 |
397 |
|
Deposit interest received |
|
49 |
43 |
102 |
|
Investment management fees paid |
|
(413) |
(384) |
(751) |
|
Other, operating expenses |
|
(243) |
(172) |
(297) |
|
Net cash flow from operating activities |
5 |
(351) |
(300) |
(549) |
|
|
|
|
|
|
|
Cash flow from investing activities |
|
|
|
|
|
Purchase of investments |
|
(3,236) |
(1,309) |
(6,819) |
|
Sale of investments |
|
1,850 |
400 |
1,493 |
|
Net cash flow from investing activities |
|
(1,386) |
(909) |
(5,326) |
|
|
|
|
|
|
|
Cash flow from financing activities |
|
|
|
|
|
Ordinary shares issued |
|
4,336 |
5,574 |
9,306 |
|
Expenses of share issues |
|
(132) |
(113) |
(201) |
|
IFA trail commission |
|
(18) |
(29) |
(29) |
|
Share buybacks for cancellation |
|
(677) |
(473) |
(1,232) |
|
Equity dividend paid |
|
(1,316) |
(1,689) |
(2,453) |
|
Net cash flow from financing activities |
|
2,183 |
3,270 |
5,391 |
|
Increase/(decrease) in cash and cash equivalents |
|
446 |
2,061 |
(484) |
|
Opening cash and cash equivalents |
|
640 |
1,124 |
1,124 |
|
Net cash increase/(decrease) |
|
446 |
2,061 |
(484) |
|
Closing cash and cash equivalents |
|
1,086 |
3,185 |
640 |
* These figures are extracts from audited accounts. The notes form an integral part of these Accounts.
CONDENSED NOTES TO THE ACCOUNTS
1. Nature of Financial Information
The Company applies FRS 102 and the Association of Investment Companies ("AIC") SORP for its financial period ended September 2025 in its Financial Statements. The financial statements for the six months to 30 September 2025 have therefore been prepared in accordance with FRS 104 "Interim Financial Reporting". The condensed financial statements have been prepared on the same basis as the accounting policies set out in the statutory accounts for the period ended 31 March 2025.
The financial information contained in this Half Year Report and Accounts and the comparative figures for the financial year ended 31 March 2025 are not the Company's statutory accounts for the financial period as defined in the Companies Act 2006. The financial information for the periods ended 30 September 2025 and 30 September 2024 have not been audited.
The Annual Report and Financial Statements for the financial year ended 31 March 2025 have been delivered to the Registrar of Companies. The report of the auditors was: (i) unqualified; (ii) did not include a reference to any matters which the auditors drew attention by way of emphasis without qualifying the report; and (iii) did not contain statements under section 498 (2) and (3) of the Companies Act 2006.
The financial statements have been prepared on a going concern basis and on the basis that approval as an investment trust company will continue to be met.
2. Return per Share (Basic and diluted)
|
|
6 Months Ended |
6 Months Ended |
12 Months Ended |
||||||
|
|
30 September 2025 |
30 September 2024 |
31 March 2025 |
||||||
|
|
Revenue |
Capital |
Total |
Revenue |
Capital |
Total |
Revenue |
Capital |
Total |
|
|
pence |
pence |
pence |
pence |
pence |
pence |
pence |
pence |
pence |
|
|
|
|
|
|
|
|
|
|
|
|
Return per Ordinary share |
(0.05) |
(0.60) |
(0.65) |
0.22 |
(1.74) |
(1.52) |
0.30 |
1.50 |
1.80 |
Revenue return per Ordinary share is based on the net revenue loss on ordinary activities after taxation of £43,000 (30 September 2024: gain £151,000, 31 March 2025: gain £217,000) and on 81,437,029 (30 September 2024: 69,107,223, 31 March 2025: 71,592,127) Ordinary shares, being the weighted average number of Ordinary shares in issue during the period.
Capital return per Ordinary share is based on the net capital loss for the period of £492,000 (30 September 2024: loss £1,201,000, 31 March 2025: gain £1,075,000) and on 81,437,029 (30 September 2024: 69,107,223, 31 March 2025: 71,592,127) Ordinary shares, being the weighted average number of Ordinary shares in issue during the period.
Total return per Ordinary share is based on the net loss on ordinary activities for the period of £535,000 (31 September 2024: loss £1,050,000, 31 March 2025: gain £1,292,000) and on 81,437,029 (30 September 2024: 69,107,223, 31 March 2025: 71,592,127) Ordinary shares, being the weighted average number of Ordinary shares in issue during the period.
3. Taxation on Ordinary Activities
The estimated effective tax rate at the period end is 0 per cent. This remains unchanged from the prior year end.
4. Net Asset Value per Share
|
|
30 September |
30 September |
31 March |
|
|
2025 |
2024 |
2025 |
|
|
Pence |
Pence |
Pence |
|
|
|
|
|
|
Net asset value per new Ordinary share |
56.43 |
57.20 |
59.04 |
The basic net asset value per new Ordinary share is based on net assets (including current period revenue) of £47,183,000 (30 September 2024: £41,289,000, 31 March 2025: £45,713,000) and on 83,612,443 (30 September 2024: 72,181,123, 31 March 2025: 77,430,445) Ordinary shares, being the number of new Ordinary shares in issue at the period end.
5. Reconciliation of Net Profit before Tax to Cash Flow from Operating Activities
|
|
30 September |
30 September |
31 March |
|
|
2025 |
2024 |
2025 |
|
|
£'000 |
£'000 |
£'000 |
|
|
|
|
|
|
(Loss)/profit on ordinary activities before tax |
(535) |
(1,050) |
1,292 |
|
(Gain)/loss on investments |
143 |
934 |
(1,617) |
|
Increase in debtors |
113 |
(106) |
(181) |
|
(Decrease)/increase in creditors |
40 |
(46) |
(10) |
|
Non cash movement |
(112) |
(32) |
(33) |
|
|
|
|
|
|
Cash flow from operating activities |
(351) |
(300) |
(549) |
6. Called up share capital
|
|
|
30 September |
|
|
|
2025 |
|
|
Number |
£'000 |
|
|
|
|
|
Ordinary shares of 1p each |
83,612,443 |
836 |
In April 2025 the Company issued 3,807,071 Ordinary shares for a total consideration of £2,133,000. In June 2025, the Company bought back for cancellation 1,272,643 Ordinary shares for a total consideration of £677,000. In July 2025, 1,484,707 Ordinary shares were issued for a total consideration of £832,000 and a further 2,162,683 Ordinary shares were issued in September 2025 for a total consideration of £1,274,000.
Following the issues and cancellation noted above there were 83,612,443 Ordinary shares in issue as at 30 September 2025.
7. Contingent assets and contingent liabilities
There were no contingent assets or contingent liabilities in existence at 30 September 2025 (30 September 2024: £nil, 31 March 2025: £nil).
8. Fair Value Hierarchy
Investments held at fair value through profit or loss are valued in accordance with IPEV guidelines.
The valuation method used will be the most appropriate valuation methodology for an investment within its market, with regard to the financial health of the investment and the IPEV guidelines. As required by the Standard, an analysis of financial assets and liabilities, which identifies the risk of the Company's holding of such items is provided. The Standard requires an analysis of investments carried at fair value based on the reliability and significance of the information used to measure their fair value.
In order to provide further information on the valuation techniques used to measure assets carried at fair value, we have categorised the measurement basis into a "fair value hierarchy" as follows:
- Quoted market prices in active markets - "Level 1"
Inputs to Level 1 fair values are quoted prices for identical asset in an active market. Quoted in an active market in this context means quoted prices are readily and regularly available and those prices represent actual and regularly occurring market transactions on an arm's length basis. The quoted price is usually the current bid price. The Company's investments in AIM quoted equities and money market funds are classified within this category.
- Valued using models with significant observable market inputs - "Level 2"
Inputs to Level 2 fair values are inputs other than quoted prices included within Level 1 that are observable for the asset, either directly or indirectly.
- Valued using models with significant unobservable market inputs - "Level 3"
Inputs to Level 3 fair values are unobservable inputs for the asset. Unobservable inputs may have been used to measure fair value to the extent that observable inputs are not available, thereby allowing for situations in which there is little, if any, market activity for the asset at the measurement date (or market information for the inputs to any valuation models). As such, unobservable inputs reflect the assumptions the Company considers that market participants would use in pricing the asset. The Company's unquoted equities and loan stock are classified within this category. Unquoted investments are valued in accordance with the IPEV guidelines.
|
|
Level 1 |
Level 2 |
Level 3 |
Total |
|
Investments |
£'000 |
£'000 |
£'000 |
£'000 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Opening book cost |
10,305 |
- |
26,564 |
36,869 |
|
Opening unrealised appreciation/(depreciation) |
(984) |
- |
7,810 |
6,826 |
|
Opening fair value |
9,321 |
- |
34,374 |
43,695 |
|
|
|
|
|
|
|
Movements in the period: |
|
|
|
|
|
Purchase at cost |
700 |
- |
3,198 |
3,898 |
|
Sales - proceeds |
- |
- |
(2,339) |
(2,339) |
|
Sales - realised losses on sales |
- |
- |
(57) |
(57) |
|
Prior year unrealised gains realised during the period |
- |
- |
316 |
316 |
|
Unrealised investment gains/(losses) |
360 |
- |
(762) |
(402) |
|
Closing fair value |
10,381 |
- |
34,730 |
45,111 |
|
|
|
|
|
|
|
Closing book cost |
11,005 |
- |
27,682 |
38,687 |
|
Closing unrealised (depreciation)/ appreciation |
(624) |
- |
7,048 |
6,424 |
|
Closing fair value |
10,381 |
- |
34,730 |
45,111 |
|
|
|
|
|
|
9. Dividends
For the year ended 31 March 2025, the Company declared a final dividend of 1.81p per share on 83,612,443 eligible shares amounting to £1,513,000. The dividend was paid on 2 October 2025.
10. Transactions with Related Parties
John Glencross, a Director of the Company, is considered to be a related party due to his position as Chief Executive and a director of Calculus Capital Limited, the Company's Investment Manager.
Calculus Capital Limited receives an investment manager's fee from the Company. For the 6 months to 30 September 2025, Calculus Capital Limited earned £465,522 of Management Fees. (30 September 2024: £355,572; 31 March 2025: £722,988). Calculus Capital Limited also earned a company secretarial fee of £45,000 (30 September 2024: £9,000; 31 March 2025: £18,000).
At 30 September 2025, £260,084 was due to Calculus Capital Limited (30 September 2024: £189,632; 31 March 2025: £189,793) in relation to unpaid investment manager's and company secretarial fees.
Calculus Capital Limited took on the expenses cap on 15 December 2015. In the 6 months to 30 September 2025, Calculus Capital Limited did not contribute towards the expenses. (30 September 2024: contributed £nil; 31 March 2025: contributed £nil).
11. Transactions with Investment Managers
John Glencross, a Director of the Company, is Chief Executive and a director of Calculus Capital Limited, the Company's Manager. He does not receive any remuneration from the Company. He is a director of Brouhaha Entertainment Limited, Home Team Content Limited, Maven Screen Media Limited, Raindog Films Limited, Riff Raff Entertainment Limited and Wonderhood Studios Limited.
Calculus Capital receives fees from certain portfolio companies. The aggregate net amounts received by Calculus Capital Limited for any monitoring, provision of a director and arrangement fees, as appropriate, from the investee companies was £418,000 for the period to 30 September 2025 (£444,000 to 30 September 2024; £1,168,000 to 31 March 2025).
12. Post balance sheet events
In October 2025, the Company made two new investments for £990,000 and £687,000 in Trogenix Limited and Grateful Limited respectively.
In October 2025, a dividend of 1.81p per share was distributed to all eligible shareholders, achieving the Company's target dividend yield of 5%. During the same month, over £1 million was raised through a combination of an allotment and the Company's dividend reinvestment scheme.
Since the period end, the Company has repurchased and cancelled an additional 707,389 shares at a price of 54.30p per share.
As mentioned above, in November 2025, the Company also exited Mo (Thanksbox Limited) representing a 1.51x return, further supporting the fund's annual target tax-free dividend yield for shareholders.
COMPANY INFORMATION
|
Directors |
Fund Administrator |
|
Jan Ward |
Waystone Administration Solutions (UK) Limited |
|
Hemant Mardia |
Broadwalk House |
|
|
Southernhay West |
|
|
Exeter EX1 1TS |
|
|
|
|
|
|
|
Registered Office |
Auditors |
|
12 Conduit Street |
MHA Audit Services LLP |
|
London |
2 London Wall Place |
|
W1S 2XH |
London EC2Y 5AU |
|
Telephone: 020 7493 4940 |
|
|
|
Broker |
|
Company Number |
Singer Capital Markets |
|
07142153 |
1 Bartholomew Lane |
|
|
London EC2N 2AX
|
|
|
|
|
Venture Capital Investments Manager |
Registrars |
|
And Company Secretary |
The City Partnership (UK) Limited |
|
Calculus Capital Limited |
The Mending Rooms |
|
12 Conduit Street |
Park Valley Mills |
|
London |
Meltham Road |
|
W1S 2XH |
Huddersfield |
|
Telephone: 020 7493 4940 |
HD4 7BH |
|
Website: www.calculuscapital.com |
|
|
|
|
|
|
|
|
Sponsor Howard Kennedy LLP 1 London Bridge
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Legal Entity Identifier: 2138005SMDWLMMNPVA90
Printed copies of the Calculus VCT plc Half Yearly Report for the six months ended 30 September 2025 have not been posted to shareholders. However, a copy can be found on the following website: https://calculuscapital.com/products/calculus-vct/investor-information/
For further information, please contact:
Calculus Capital Limited
Telephone: 020 7493 4940
Neither the contents of the Company's website nor the contents of any website accessible from hyperlinks on this announcement (or any other website) are incorporated into, or form part of, this announcement.
END
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Proactive Investors is a publisher of financial news and information. No content in this record, or published on the Proactive Investors website (the "Site"), constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. No content is tailored to any specific person's needs, objectives, or financial situation.
Proactive Investors is not a registered investment adviser or broker-dealer and does not provide personalized investment advice. Nothing in this record constitutes investment advice or a recommendation to buy, hold, or sell any security. None of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value, or suitability of any particular security, portfolio, transaction, or investment strategy. Any decision to buy, sell, or hold a security should be made only after consulting an appropriately qualified, licensed financial adviser and reading all relevant offering documentation.
This record, and any record we publish by or on behalf of our clients, should not be construed as an offer or solicitation to buy or sell any product or security. Our content is independent financial journalism, produced in a neutral, objective style with full source attribution.
In accordance with the Federal Trade Commission's guidelines on material connections, Proactive Investors discloses the following: we may receive cash or, in some cases, equity compensation from companies whose news is distributed through our platform. This compensation is for news distribution and media services, not for editorial content or coverage decisions. Where Proactive Investors has a commercial relationship with a company covered in this record, that relationship is disclosed within the article. Any such relationship does not determine, influence, or shape the editorial content produced. Where we receive equity compensation, such securities are held independently by a third-party broker and sold at the broker's discretion.
The Site may contain opinions from time to time regarding securities mentioned in other products, including company-related products, and those opinions may differ from those obtained through another Proactive Investors product. Opinions and commentary reflect the views of the named author at the time of writing and are subject to change without notice.
Price and other data is supplied by sources believed to be reliable. Any calculations are made using such data. Neither the data nor the calculations are guaranteed by those sources, by Proactive Investors, by the information providers, or by any other person or entity, and may not be complete or accurate.
From time to time, reference may be made in our marketing materials to previously published articles or opinions. Such references may be selective, may reference only a portion of an article, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.
FOR OUR FULL DISCLAIMER CLICK HERE